Benefits and Programme Portfolio Review
Public-sector portfolios contain programmes with different objectives, beneficiaries, time horizons and evidence. A single ranking score can create false comparability between them. Portfolio review must instead determine which programmes should expand, change, combine, pause or stop while preserving the reasons behind each choice.
Spending and activity do not establish public value
A programme may spend its budget, reach its delivery milestones and still fail to improve the intended outcome. Another programme may show promising early results before its long-term benefits can be observed. Comparing both through expenditure or activity rewards delivery volume rather than value.
Management needs a benefit chain for each programme. The chain connects resources, delivery, reach, intermediate change and the intended public outcome. Evidence should be assessed at each link so that the review can distinguish weak implementation from an implausible programme design.
Different outcomes require a common decision, not a common unit
Health, safety, access, economic and environmental outcomes cannot always be converted into one defensible monetary score. Forcing that conversion can hide ethical priorities and distributional effects. However, management still needs to allocate limited resources.
A structured decision model can compare programmes across several explicit criteria. The criteria may include expected benefit, evidence strength, strategic necessity, distribution, delivery risk, cost and reversibility. Weights and trade-offs should remain visible so that the final choice reflects management judgement rather than an opaque calculation.
Staged investment preserves the option to learn
Uncertainty does not require an immediate choice between full expansion and cancellation. A programme may be piloted, expanded in stages or paused while new evidence is collected. Real-options analysis values this ability to learn before committing the full budget.
The review should identify which uncertainty affects the decision and whether further evidence could resolve it. If additional research would not change the choice, delaying the programme creates cost without information value. If one uncertain assumption determines the result, a targeted test may be more valuable than a larger general evaluation.
Dependencies can change an apparently strong programme
Consider a digital service programme that depends on identity infrastructure, staff capability and another agency's data. Its direct business case may appear strong. Yet the expected benefit will not occur on schedule if those dependencies remain unresolved.
Marketways would map the dependency, test the delivery sequence and compare staged options. Management could then fund enabling capability first, combine related programmes or delay the dependent investment. The review would show how the portfolio decision changes when delivery maturity and dependency risk are included.
AI can maintain evidence, not choose public priorities
An AI workflow can retrieve programme reports, track assumptions and alert managers when evidence or dependencies change. It can also prepare consistent comparisons across a large portfolio. These tasks improve the timeliness of review.
The workflow should not determine the relative importance of public outcomes or make funding decisions. Leaders must approve the criteria, trade-offs and distributional priorities. The system should preserve the evidence and judgement behind every recommendation.
A portfolio decision needs a review trigger
Management should record why each programme will expand, change, combine, pause or stop. The record should include expected outcomes, evidence strength, resource requirement, dependencies and the condition that would reopen the decision.
Outcome per resource can inform the comparison, but it should not replace programme-specific success measures. Implementation progress and evidence maturity show whether management is learning enough to justify the next commitment.
How Marketways supports portfolio decisions
Marketways defines the decision criteria, reconstructs each programme's benefit chain and assesses the strength of the available evidence. We model dependencies, uncertainty and staged options before helping leaders compare the portfolio.
The engagement may combine Decision Assurance, Business Feasibility Study and Decision Analysis and Prioritisation. The result is a traceable allocation decision rather than a league table of unlike programmes.